Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 725,788 | 665,700 | 625,740 | 610,412 | 597,027 |
| Cost of Goods | 55,593 | 46,379 | 43,572 | 48,114 | 38,573 |
| Gross Profit | 670,195 | 619,321 | 582,168 | 562,298 | 558,454 |
| Operating Expenses | 482,324 | 391,610 | 391,178 | 367,317 | 322,225 |
| Operating Income | 188,464 | 228,090 | 191,562 | 195,095 | 236,802 |
| Interest Expense | 9,232 | 10,177 | 11,613 | 11,661 | 11,736 |
| Other Income | 2,591 | -9,110 | 937 | -2,259 | 618 |
| Pre-tax Income | 181,823 | 208,803 | 180,886 | 181,175 | 225,684 |
| Income Tax | 98,448 | 112,452 | 112,581 | 94,993 | 84,378 |
| Net Income Continuous | 83,375 | 96,351 | 68,305 | 86,182 | 141,306 |
| Net Income | $83,375 | $96,351 | $68,305 | $86,182 | $141,306 |
| EPS Basic Total Ops | 0.83 | 0.96 | 0.69 | 0.88 | 1.44 |
| EPS Basic Continuous Ops | 0.83 | 0.96 | 0.69 | 0.87 | 1.44 |
| EPS Diluted Total Ops | 0.73 | 0.85 | 0.61 | 0.78 | 1.25 |
| EPS Diluted Continuous Ops | 0.71 | 0.85 | 0.61 | 0.82 | 1.21 |
| EBITDA(a) | $202,469 | $241,106 | $203,092 | $206,387 | $247,605 |